Sinocelltech Group Limited (SHA:688520)

China flag China · Delayed Price · Currency is CNY
33.85
+0.70 (2.11%)
Jul 31, 2026, 3:00 PM CST
Market Cap15.92B -52.3%
Revenue (ttm)1.36B -43.7%
Net Income-804.31M
EPS-1.95
Shares Out 470.34M
PE Ration/a
Forward PE36.01
Dividendn/a
Ex-Dividend Daten/a
Volume1,801,314
Open33.20
Previous Close33.15
Day's Range33.18 - 34.13
52-Week Range31.35 - 81.32
Beta0.57
Analystsn/a
Price Targetn/a
Earnings DateAug 29, 2026

About Sinocelltech Group

Sinocelltech Group Limited, a biopharmaceutical company, engages in the research, development, and production of recombinant proteins, antibody drugs, viral infections, and vaccines in China. The company offers Anjiayin, a third-generation recombinant coagulation factor VIII product for the treatment of hemophilia A; Anpingxi, an anti-CD20 monoclonal antibody for the treatment of CD20-positive diffuse large B-cell non-Hodgkin's lymphoma; Anjiarun, an adalimumab biosimilar for the treatment of various autoimmune diseases; Anbezu, a bevacizumab b... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,200
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688520
Full Company Profile

Financial Performance

Financial Statements